SNOA
Price
$2.71
Change
+$0.08 (+3.04%)
Updated
Dec 23, 04:59 PM (EDT)
TAK
Price
$13.18
Change
+$0.08 (+0.61%)
Updated
Dec 23, 04:59 PM (EDT)
37 days until earnings call
Ad is loading...

SNOA vs TAK

Header iconSNOA vs TAK Comparison
Open Charts SNOA vs TAKBanner chart's image
Sonoma Pharmaceuticals
Price$2.71
Change+$0.08 (+3.04%)
Volume$2.2K
CapitalizationN/A
Takeda Pharmaceutical
Price$13.18
Change+$0.08 (+0.61%)
Volume$27.51K
CapitalizationN/A
SNOA vs TAK Comparison Chart
Loading...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNOA vs. TAK commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNOA is a Hold and TAK is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (SNOA: $2.68 vs. TAK: $13.17)
Brand notoriety: SNOA and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SNOA: 9% vs. TAK: 112%
Market capitalization -- SNOA: $2.39M vs. TAK: $43.11B
SNOA [@Pharmaceuticals: Other] is valued at $2.39M. TAK’s [@Pharmaceuticals: Other] market capitalization is $43.11B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNOA’s FA Score shows that 0 FA rating(s) are green whileTAK’s FA Score has 1 green FA rating(s).

  • SNOA’s FA Score: 0 green, 5 red.
  • TAK’s FA Score: 1 green, 4 red.
According to our system of comparison, TAK is a better buy in the long-term than SNOA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNOA’s TA Score shows that 2 TA indicator(s) are bullish while TAK’s TA Score has 4 bullish TA indicator(s).

  • SNOA’s TA Score: 2 bullish, 6 bearish.
  • TAK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TAK is a better buy in the short-term than SNOA.

Price Growth

SNOA (@Pharmaceuticals: Other) experienced а +1.13% price change this week, while TAK (@Pharmaceuticals: Other) price change was -0.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.13%. For the same industry, the average monthly price growth was -0.78%, and the average quarterly price growth was -8.74%.

Reported Earning Dates

SNOA is expected to report earnings on Nov 08, 2024.

TAK is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($43.1B) has a higher market cap than SNOA($2.39M). TAK YTD gains are higher at: -5.795 vs. SNOA (-25.721). TAK has higher annual earnings (EBITDA): 1.01T vs. SNOA (-4.27M). TAK has more cash in the bank: 317B vs. SNOA (2.41M). SNOA has less debt than TAK: SNOA (385K) vs TAK (4.66T). TAK has higher revenues than SNOA: TAK (4.17T) vs SNOA (12.3M).
SNOATAKSNOA / TAK
Capitalization2.39M43.1B0%
EBITDA-4.27M1.01T-0%
Gain YTD-25.721-5.795444%
P/E RatioN/A36.79-
Revenue12.3M4.17T0%
Total Cash2.41M317B0%
Total Debt385K4.66T0%
FUNDAMENTALS RATINGS
SNOA vs TAK: Fundamental Ratings
SNOA
TAK
OUTLOOK RATING
1..100
8782
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
7
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9883
PRICE GROWTH RATING
1..100
8358
P/E GROWTH RATING
1..100
6192
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (7) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNOA (72) in the Pharmaceuticals Other industry. This means that TAK’s stock grew somewhat faster than SNOA’s over the last 12 months.

TAK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SNOA (100) in the Pharmaceuticals Other industry. This means that TAK’s stock grew similarly to SNOA’s over the last 12 months.

TAK's SMR Rating (83) in the Pharmaceuticals Major industry is in the same range as SNOA (98) in the Pharmaceuticals Other industry. This means that TAK’s stock grew similarly to SNOA’s over the last 12 months.

TAK's Price Growth Rating (58) in the Pharmaceuticals Major industry is in the same range as SNOA (83) in the Pharmaceuticals Other industry. This means that TAK’s stock grew similarly to SNOA’s over the last 12 months.

SNOA's P/E Growth Rating (61) in the Pharmaceuticals Other industry is in the same range as TAK (92) in the Pharmaceuticals Major industry. This means that SNOA’s stock grew similarly to TAK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNOATAK
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
43%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
39%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
54%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
52%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
51%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
44%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
43%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 5 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 1 day ago
51%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
37%
View a ticker or compare two or three
Ad is loading...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MKSI106.242.71
+2.62%
MKS Instruments
HLP1.350.01
+0.75%
Hongli Group
SWI14.30-0.15
-1.04%
SolarWinds Corp
CPAC5.37-0.19
-3.42%
Cementos Pacasmayo SAA
ISPC2.80-0.20
-6.67%
iSpecimen Inc

SNOA and

Correlation & Price change

A.I.dvisor tells us that SNOA and BNXTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNOA and BNXTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
+1.90%
BNXTF - SNOA
29%
Poorly correlated
N/A
BGLAF - SNOA
27%
Poorly correlated
N/A
OGI - SNOA
26%
Poorly correlated
+1.28%
AKAN - SNOA
25%
Poorly correlated
+16.31%
TAK - SNOA
23%
Poorly correlated
+0.53%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with SGIOY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then SGIOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
+0.53%
SGIOY - TAK
41%
Loosely correlated
-0.14%
ESAIY - TAK
35%
Loosely correlated
-1.89%
BNXTF - TAK
32%
Poorly correlated
N/A
TKPHF - TAK
27%
Poorly correlated
-5.96%
ELAN - TAK
27%
Poorly correlated
+1.98%
More